In a mouse model of Alzheimer’s disease (AD), the fibrillar peptide amyloid beta (Aβ) can be phagocytosed by lysosomes leading to lysosomal damage and cathepsin B release, which in turn activates the NLRP3 inflammasome [50]. This evidence concerns the gene NLRP3 and Alzheimer disease.